Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for depressive symptoms in post-myocardial infarction patients
2004-000990-78Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Escitalopram (Cipralex) with Placebo (2 arms). Primary endpoint: Change in SCL-90-R depression subscale score at week 8. Started Jul 2004; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2004-000990-78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000990-78.